470 related articles for article (PubMed ID: 12746920)
21. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
Suszko A; Obmińska-Mrukowicz B
J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
[TBL] [Abstract][Full Text] [Related]
22. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
Dong L; Ito S; Ishii KJ; Klinman DM
Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
[TBL] [Abstract][Full Text] [Related]
23. Chronicity of arthritis induced with homologous type II collagen (CII) in rats is associated with anti-CII B-cell activation.
Holmdahl R; Vingsbo C; Malmström V; Jansson L; Holmdahl M
J Autoimmun; 1994 Dec; 7(6):739-52. PubMed ID: 7888032
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
[TBL] [Abstract][Full Text] [Related]
25. The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models.
Chiba A; Kaieda S; Oki S; Yamamura T; Miyake S
Arthritis Rheum; 2005 Jun; 52(6):1941-8. PubMed ID: 15934073
[TBL] [Abstract][Full Text] [Related]
26. Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis.
Doncarli A; Stasiuk LM; Fournier C; Abehsira-Amar O
Eur J Immunol; 1997 Jun; 27(6):1451-8. PubMed ID: 9209498
[TBL] [Abstract][Full Text] [Related]
27. The role of the B cells in the adoptive transfer of collagen-induced arthritis from DBA/1 (H-2q) to SCID (H-2d) mice.
Taylor PC; Plater-Zyberk C; Maini RN
Eur J Immunol; 1995 Mar; 25(3):763-9. PubMed ID: 7705406
[TBL] [Abstract][Full Text] [Related]
28. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
29. Activated type II collagen reactive T cells are not eliminated by in vivo anti-CD4 treatment. Implications for therapeutic approaches on autoimmune arthritis.
Goldschmidt TJ; Andersson M; Malmström V; Holmdahl R
Immunobiology; 1992 Apr; 184(4-5):359-71. PubMed ID: 1350565
[TBL] [Abstract][Full Text] [Related]
30. [Animal models for bone and joint disease. CIA, CAIA model].
Hirose J; Tanaka S
Clin Calcium; 2011 Feb; 21(2):253-9. PubMed ID: 21289422
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
32. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
[TBL] [Abstract][Full Text] [Related]
33. Complement receptor CR2/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens.
Kuhn KA; Cozine CL; Tomooka B; Robinson WH; Holers VM
Mol Immunol; 2008 May; 45(10):2808-19. PubMed ID: 18374982
[TBL] [Abstract][Full Text] [Related]
34. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
35. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
Cheng CP; Sytwu HK; Chang DM
J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
[TBL] [Abstract][Full Text] [Related]
36. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
37. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
[TBL] [Abstract][Full Text] [Related]
38. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
[TBL] [Abstract][Full Text] [Related]
39. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
Cantaert T; Teitsma C; Tak PP; Baeten D
Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
[TBL] [Abstract][Full Text] [Related]
40. Dipeptidyl peptidase I regulates the development of collagen-induced arthritis.
Hu Y; Pham CT
Arthritis Rheum; 2005 Aug; 52(8):2553-8. PubMed ID: 16059912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]